Manlio Fusciello

Obtained his Bachelor Degree in Molecular Biology at the University of Ferrara, Italy in 2012. After that he moved to the Netherlands to obtain a Master Degree in Biomedical Sciences at Maastricht University, concluded by completion of international thesis at the University of Toronto, Canada in 2014. After that he pursued his doctorate studies and obtained his PhD in August 2023 with distinction at the University of Helsinki at ImmunoViroTherapy lab (IVT) under the supervision of Professor Vincenzo Cerullo. During his PhD Dr. Fusciello investigated the combination of complexing pathogens with tumor associated peptides (TAAs) to created new cancer vaccines platforms eliciting specific anticancer T lymphocytes following Professor Cerullo leadership, a pioneer in this field using oncolytic adenoviruses and tumor peptides.